메뉴 건너뛰기




Volumn 19, Issue 56, 2000, Pages 6642-6650

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

Author keywords

Cancer; Emmprin; Matrix metalloproteinases (MMPs); MMP inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; BATIMASTAT; CD147 ANTIGEN; CIPEMASTAT; CISPLATIN; ENZYME ACTIVATOR; FLUOROURACIL; GELATINASE A; GEMCITABINE; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; MATRIX METALLOPROTEINASE MT1; ONYX 015; PRINOMASTAT; TANOMASTAT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

EID: 0034722898     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204097     Document Type: Review
Times cited : (515)

References (78)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.